Related Experiment Video
Updated: Aug 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
ACE inhibitors: over two decades of use
Domenic A Sica1, Thomas D Giles, Henry R Black
1Virginia Commonwealth University, Richmond, VA, USA.
Abstract:
During the meeting of the American Society of Hypertension, Inc. in San Francisco, CA, on May 16, 2005, a roundtable was convened to discuss angiotensin-converting enzyme inhibition as it relates to both blood pressure control and issues of end-organ protection. Dr. Domenic A. Sica of Virginia Commonwealth University, Richmond, VA, moderated the panel discussion. Participants included Dr. Thomas D. Giles of the Louisiana State University Health Sciences Center, New Orleans, LA, and President of The American Society of Hypertension, Inc.; Dr. Henry R. Black of Rush University Medical Center, Chicago, IL; and Dr. Vito M. Campese of the University of Southern California, Los Angeles, CA.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Hypertension IV: Drug Therapy and Lifestyle Modifications